Trials / Completed
CompletedNCT00845325
Early Motion Following Carpal Tunnel Release
Early Motion Following Carpal Tunnel Release, a Randomized Control Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- University of Missouri-Columbia · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To objectively and subjectively assess two modes of commonly employed rehabilitation and confirm a superior method to treat patients following carpal tunnel release. One of the problems following carpal tunnel release (CTR) for carpal tunnel syndrome, and all hand surgeries, is the debilitation in the postoperative period. This relates to muscle atrophy and joint stiffness due to immobilization or relative inactivity in the postoperative period. Specifically, patients suffer increased days off from work, lost wages, and difficulties with activities of daily living affecting the patient and society at large. CTR is a very common procedure in hand surgery making it easy to study and important to optimize the postoperative care.
Detailed description
The surgical procedure, carpal tunnel release, will be performed in a standard open fashion. In a random fashion, the patients will be placed into either of two rehabilitation groups following CTR with specifically different postoperative instructions after the procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Group One | They will begin exercises on the day after surgery and perform them three times daily for two weeks. The patients will have no restrictions concerning activity or return to work. |
| BEHAVIORAL | Control Group Two | The patients will be restricted from using that hand during its implementation. One week following surgery the splint will be removed and the patient will be instructed to begin activity without restriction. |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2009-02-18
- Last updated
- 2016-04-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00845325. Inclusion in this directory is not an endorsement.